Veradermics reports positive Phase 2 Study 207 results for oral VDPHL01 in female pattern hair loss by thaan@22fillmore.com | Jul 15, 2026 | Portfolio News
Kestra Medical Technologies secures up to $200M of non-dilutive financing by thaan@22fillmore.com | Jul 14, 2026 | Portfolio News
Endogenex completes enrollment of 350 patients in the pivotal ReCET study of its endoscopic treatment for type 2 diabetes by thaan@22fillmore.com | Jul 8, 2026 | Portfolio News
Vera Therapeutics receives FDA accelerated approval of Trutakna (atacicept) for adults with primary IgA nephropathy by thaan@22fillmore.com | Jul 7, 2026 | Portfolio News
Viridian Therapeutics receives FDA approval of Lumvoa (veligrotug) for thyroid eye disease and begins commercial launch by thaan@22fillmore.com | Jun 26, 2026 | Portfolio News
Murj expands into Australia and New Zealand with commercial launch of its cardiac device management platform by thaan@22fillmore.com | Jun 22, 2026 | Portfolio News
cAMPfield Therapeutics launches with $180M Series A to advance oral PDE4B inhibitor prifemilast in inflammatory bowel disease by thaan@22fillmore.com | Jun 18, 2026 | Portfolio News
Lexeo Therapeutics finalizes SUNRISE-FA 2 pivotal trial design for LX2006 gene therapy in Friedreich ataxia cardiomyopathy by thaan@22fillmore.com | Jun 15, 2026 | Portfolio News
Mirum Pharmaceuticals and Incyte report positive pivotal Phase 2 PROGRESS results for zilurgisertib in fibrodysplasia ossificans progressiva by thaan@22fillmore.com | Jun 14, 2026 | Portfolio News
Zenas BioPharma submits Biologics License Application to the FDA for obexelimab in IgG4-related disease by thaan@22fillmore.com | May 28, 2026 | Portfolio News
